'Commands by Mind, Instantly Executed'... Ybrain Takes on Challenge to Commercialize BCI by 2035
Participation in the National BCI Ecosystem 'BCI Alliance'
Sharing Clinical and Commercialization Experience
Ybrain, a company specializing in electroceuticals and brain-computer interfaces (BCI), is participating in the government's initiative to establish a BCI industry ecosystem. Ybrain emphasized that it would leverage its technologies and data accumulated throughout the development of medical devices, clinical trials, and commercialization processes to help ensure that domestic BCI research outcomes are ultimately adopted in actual medical settings and commercial products.
Lee Eog-weon, CEO of Ybrain, is delivering a presentation at the launch ceremony of the BCI Alliance held on the 26th. Photo by Ybrain
View original imageAccording to industry sources on August 27th, Ybrain was the only company to co-host the "BCI Alliance Launch Ceremony," which took place at The Plaza Hotel in Seoul on August 26th. The event was hosted by the Ministry of Science and ICT and jointly organized by the National Research Foundation of Korea, Korea Brain Research Institute, Ybrain, and the Korea BCI Association.
BCI refers to technology that measures and interprets brain and neural signals to control external devices such as computers or medical equipment. It is considered a next-generation brain science technology because it can be used not only for the diagnosis, treatment, rehabilitation, and communication support of neurological disorders, but also for controlling external devices such as robots.
Ybrain has spent the past 13 years developing technologies for brain and neural signal analysis and control. Based on this expertise, the company has developed non-invasive electroceuticals for mental health applications such as depression and insomnia, and has undertaken medical device development, clinical trials, hospital supply, and at-home treatment services. Ybrain has also accumulated more than 1.4 million real-life brain and neural activity data points from clinical settings.
Ybrain plans to share its clinical and commercialization expertise and data with other BCI Alliance participants. The company aims to connect foundational technologies developed at universities and research institutions with product development capabilities in industry, and to play a key role as a private company in the process of verifying clinical effectiveness and field applicability through hospitals.
On this day, Lee Eog-weon, CEO of Ybrain, presented the background of establishing the alliance and outlined upcoming activities. In the subsequent policy forum, he addressed the topic "Strategies to Foster the Domestic BCI Industry and Directions for Policy Support," presenting key tasks for linking research and development, industry, clinical, and regulatory sectors.
Lee stated, “For BCI technology to lead to real innovation in healthcare and industry that the public can benefit from, it is crucial to connect field experience with technical expertise. Drawing on our accumulated knowledge in clinical and commercialization processes, we aim to contribute to the growth and competitiveness of the domestic BCI ecosystem.”
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, the BCI Alliance will be operated with a focus on three divisions: research and development (R&D), commercialization, and infrastructure establishment. It is structured to enable both government and private sectors to discuss the infrastructure and systems needed throughout the process—from research and development to clinical trials, regulatory approvals, and commercialization. Science and ICT Second Vice Minister and Minister of Science and ICT Bae Kyunghoon, together with Korea BCI Association President Baek Namjong, are serving as co-chairs.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.